Page last updated: 2024-08-18

pyridostigmine bromide and amyloid beta-peptides

pyridostigmine bromide has been researched along with amyloid beta-peptides in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adani, R; Amitai, G; Avila, J; Farías, GG; Godoy, JA; Inestrosa, NC; Meshulam, H; Vázquez, MC1

Other Studies

1 other study(ies) available for pyridostigmine bromide and amyloid beta-peptides

ArticleYear
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
    Neurobiology of disease, 2005, Volume: 18, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Brain; Cells, Cultured; Cholinesterase Inhibitors; Cytoskeletal Proteins; Disease Models, Animal; Down-Regulation; Drug Compounding; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Ibuprofen; Intercellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Pyridinium Compounds; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Signal Transduction; Trans-Activators; Wnt Proteins

2005